The global pancrelipase market was valued at $1,760.41 million in 2021, and is estimated to reach $2,687.39 million by 2031, growing at a CAGR of 4.3% from 2022 to 2031.
Purified porcine pancreatic lipase, amylase, and protease enzymes are used to make pancrelipase. In diseases where the pancreas is not functioning properly, such as cystic fibrosis and pancreatitis, pancrelipase is utilized to aid in improving food digestion. The lipases, proteases, and amylases included in pancrelipase are necessary for the breakdown of proteins, carbohydrates, and lipids.
The major factors that drive the growth of the pancrelipase market is increase in the increase in prevalence of chronic pancreatitis, cystic fibrosis and changing dietary habits &lifestyle, are the factors attributed to the growth of the pancrelipase market. In addition, primarily pancreatic insufficiency is a key trend of the market which is expected to fuel the growth in the forecast period. The pancreas is inflamed by pancreatitis. Chronic pancreatitis, or pancreatitis that lasts for a long time, can occur in some persons. Adults with chronic pancreatitis or those who have undergone pancreas removal surgery can enhance their food digestion by taking pancrelipase pills coupled with a proton pump inhibitor (PPI). Increase in incidence of the pancreatitis drives the market growth.
Rise in prevalence of the digestive diseases drives pancrelipase market. For an instance According to the NCBI, National Center for Biotechnology Information, gastrointestinal diseases affect an estimated 60 to 70 million people annually in America. Thus, there is a growing prevalence of the digestive diseases around the globe which further highlights the need for the pancrelipase drugs causing the market growth
However high cost associated with drug development, patents of the branded drugs are expected to hinder the growth of the market. Conversely, growth opportunities in emerging market to suffice the consumer demands is expected to provide a great opportunity for the investors to invest in the market.
The global pancrelipase market is segmented on the basis of application, age, distribution channel and region. On the basis of application, the market is categorized into chronic pancreatitis, cystic fibrosis and others. By age, it is segmented into children and adult & geriatric. By distribution channel, it is segmented into hospital pharmacies, drug store and retail pharmacies and online pharmacies. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and Latin America, the Middle East, and Africa (LAMEA).
The major players profiled in the report are Abbvie Inc, Digestive Care, Inc, Nestlé S. A., Organon Canada Inc., Viatris Inc., and Vivus LLC.
Purified porcine pancreatic lipase, amylase, and protease enzymes are used to make pancrelipase. In diseases where the pancreas is not functioning properly, such as cystic fibrosis and pancreatitis, pancrelipase is utilized to aid in improving food digestion. The lipases, proteases, and amylases included in pancrelipase are necessary for the breakdown of proteins, carbohydrates, and lipids.
The major factors that drive the growth of the pancrelipase market is increase in the increase in prevalence of chronic pancreatitis, cystic fibrosis and changing dietary habits &lifestyle, are the factors attributed to the growth of the pancrelipase market. In addition, primarily pancreatic insufficiency is a key trend of the market which is expected to fuel the growth in the forecast period. The pancreas is inflamed by pancreatitis. Chronic pancreatitis, or pancreatitis that lasts for a long time, can occur in some persons. Adults with chronic pancreatitis or those who have undergone pancreas removal surgery can enhance their food digestion by taking pancrelipase pills coupled with a proton pump inhibitor (PPI). Increase in incidence of the pancreatitis drives the market growth.
Rise in prevalence of the digestive diseases drives pancrelipase market. For an instance According to the NCBI, National Center for Biotechnology Information, gastrointestinal diseases affect an estimated 60 to 70 million people annually in America. Thus, there is a growing prevalence of the digestive diseases around the globe which further highlights the need for the pancrelipase drugs causing the market growth
However high cost associated with drug development, patents of the branded drugs are expected to hinder the growth of the market. Conversely, growth opportunities in emerging market to suffice the consumer demands is expected to provide a great opportunity for the investors to invest in the market.
The global pancrelipase market is segmented on the basis of application, age, distribution channel and region. On the basis of application, the market is categorized into chronic pancreatitis, cystic fibrosis and others. By age, it is segmented into children and adult & geriatric. By distribution channel, it is segmented into hospital pharmacies, drug store and retail pharmacies and online pharmacies. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and Latin America, the Middle East, and Africa (LAMEA).
The major players profiled in the report are Abbvie Inc, Digestive Care, Inc, Nestlé S. A., Organon Canada Inc., Viatris Inc., and Vivus LLC.
KEY BENEFITS FOR STAKEHOLDERS
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the pancrelipase market analysis from 2021 to 2031 to identify the prevailing pancrelipase market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the pancrelipase market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global pancrelipase market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Age
- Children
- Adults and Geriatrics
By Application
- Chronic Pancreatitis
- Cystic Fibrosis
- Others
By Distribution Channel
- Online Pharmacies
- Hospital Pharmacies
- Drug Store and Retail Pharmacies
By Region
- North America
- U. S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- Rest of Asia-Pacific
- LAMEA
- Latin America
- Middle East Africa
Key Market Players
- Abbvie Inc
- Digestive Care, Inc.
- Nestlé S. A
- Organon Canada Inc.
- Viatris Inc.
- Vivus Llc
Table of Contents
CHAPTER 1: INTRODUCTION1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Porter’s five forces analysis
3.4. Top player positioning
3.5. Market dynamics
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
3.6. COVID-19 Impact Analysis on the market
CHAPTER 4: PANCRELIPASE MARKET, BY APPLICATION
4.1 Overview
4.1.1 Market size and forecast
4.2 Chronic Pancreatitis
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market share analysis by country
4.3 Cystic Fibrosis
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market share analysis by country
4.4 Others
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market share analysis by country
CHAPTER 5: PANCRELIPASE MARKET, BY AGE
5.1 Overview
5.1.1 Market size and forecast
5.2 Children
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market share analysis by country
5.3 Adults and Geriatrics
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market share analysis by country
CHAPTER 6: PANCRELIPASE MARKET, BY DISTRIBUTION CHANNEL
6.1 Overview
6.1.1 Market size and forecast
6.2 Hospital Pharmacies
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market share analysis by country
6.3 Drug Store and Retail Pharmacies
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market share analysis by country
6.4 Online Pharmacies
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market share analysis by country
CHAPTER 7: PANCRELIPASE MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key trends and opportunities
7.2.2 North America Market size and forecast, by Application
7.2.3 North America Market size and forecast, by Age
7.2.4 North America Market size and forecast, by Distribution Channel
7.2.5 North America Market size and forecast, by country
7.2.5.1 U. S.
7.2.5.1.1 Key market trends, growth factors and opportunities
7.2.5.1.2 Market size and forecast, by Application
7.2.5.1.3 Market size and forecast, by Age
7.2.5.1.4 Market size and forecast, by Distribution Channel
7.2.5.2 Canada
7.2.5.2.1 Key market trends, growth factors and opportunities
7.2.5.2.2 Market size and forecast, by Application
7.2.5.2.3 Market size and forecast, by Age
7.2.5.2.4 Market size and forecast, by Distribution Channel
7.2.5.3 Mexico
7.2.5.3.1 Key market trends, growth factors and opportunities
7.2.5.3.2 Market size and forecast, by Application
7.2.5.3.3 Market size and forecast, by Age
7.2.5.3.4 Market size and forecast, by Distribution Channel
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Application
7.3.3 Europe Market size and forecast, by Age
7.3.4 Europe Market size and forecast, by Distribution Channel
7.3.5 Europe Market size and forecast, by country
7.3.5.1 Germany
7.3.5.1.1 Key market trends, growth factors and opportunities
7.3.5.1.2 Market size and forecast, by Application
7.3.5.1.3 Market size and forecast, by Age
7.3.5.1.4 Market size and forecast, by Distribution Channel
7.3.5.2 France
7.3.5.2.1 Key market trends, growth factors and opportunities
7.3.5.2.2 Market size and forecast, by Application
7.3.5.2.3 Market size and forecast, by Age
7.3.5.2.4 Market size and forecast, by Distribution Channel
7.3.5.3 UK
7.3.5.3.1 Key market trends, growth factors and opportunities
7.3.5.3.2 Market size and forecast, by Application
7.3.5.3.3 Market size and forecast, by Age
7.3.5.3.4 Market size and forecast, by Distribution Channel
7.3.5.4 Rest of Europe
7.3.5.4.1 Key market trends, growth factors and opportunities
7.3.5.4.2 Market size and forecast, by Application
7.3.5.4.3 Market size and forecast, by Age
7.3.5.4.4 Market size and forecast, by Distribution Channel
7.4 Asia-Pacific
7.4.1 Key trends and opportunities
7.4.2 Asia-Pacific Market size and forecast, by Application
7.4.3 Asia-Pacific Market size and forecast, by Age
7.4.4 Asia-Pacific Market size and forecast, by Distribution Channel
7.4.5 Asia-Pacific Market size and forecast, by country
7.4.5.1 Japan
7.4.5.1.1 Key market trends, growth factors and opportunities
7.4.5.1.2 Market size and forecast, by Application
7.4.5.1.3 Market size and forecast, by Age
7.4.5.1.4 Market size and forecast, by Distribution Channel
7.4.5.2 China
7.4.5.2.1 Key market trends, growth factors and opportunities
7.4.5.2.2 Market size and forecast, by Application
7.4.5.2.3 Market size and forecast, by Age
7.4.5.2.4 Market size and forecast, by Distribution Channel
7.4.5.3 India
7.4.5.3.1 Key market trends, growth factors and opportunities
7.4.5.3.2 Market size and forecast, by Application
7.4.5.3.3 Market size and forecast, by Age
7.4.5.3.4 Market size and forecast, by Distribution Channel
7.4.5.4 Australia
7.4.5.4.1 Key market trends, growth factors and opportunities
7.4.5.4.2 Market size and forecast, by Application
7.4.5.4.3 Market size and forecast, by Age
7.4.5.4.4 Market size and forecast, by Distribution Channel
7.4.5.5 Rest of Asia-Pacific
7.4.5.5.1 Key market trends, growth factors and opportunities
7.4.5.5.2 Market size and forecast, by Application
7.4.5.5.3 Market size and forecast, by Age
7.4.5.5.4 Market size and forecast, by Distribution Channel
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Application
7.5.3 LAMEA Market size and forecast, by Age
7.5.4 LAMEA Market size and forecast, by Distribution Channel
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Latin America
7.5.5.1.1 Key market trends, growth factors and opportunities
7.5.5.1.2 Market size and forecast, by Application
7.5.5.1.3 Market size and forecast, by Age
7.5.5.1.4 Market size and forecast, by Distribution Channel
7.5.5.2 Middle East & Africa
7.5.5.2.1 Key market trends, growth factors and opportunities
7.5.5.2.2 Market size and forecast, by Application
7.5.5.2.3 Market size and forecast, by Age
7.5.5.2.4 Market size and forecast, by Distribution Channel
CHAPTER 8: COMPANY LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Players
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments
CHAPTER 9: COMPANY PROFILES
9.1 Abbvie Inc
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Operating business segments
9.1.4 Product portfolio
9.1.5 Business performance
9.1.6 Key strategic moves and developments
9.2 Digestive Care, Inc.
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Operating business segments
9.2.4 Product portfolio
9.2.5 Business performance
9.2.6 Key strategic moves and developments
9.3 Nestlé S. A
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Operating business segments
9.3.4 Product portfolio
9.3.5 Business performance
9.3.6 Key strategic moves and developments
9.4 Organon Canada Inc.
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Product portfolio
9.4.5 Business performance
9.4.6 Key strategic moves and developments
9.5 Viatris Inc.
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Operating business segments
9.5.4 Product portfolio
9.5.5 Business performance
9.5.6 Key strategic moves and developments
9.6 Vivus Llc
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Product portfolio
9.6.5 Business performance
9.6.6 Key strategic moves and developments
Executive Summary
According to this report, titled, 'Pancrelipase Market,' the pancrelipase market was valued at $1.8 billion in 2021, and is estimated to reach $2.7 billion by 2031, growing at a CAGR of 4.3% from 2022 to 2031.An exocrine pancreatic insufficiency-related class of drugs known as pancrelipase is used to treat malabsorption of nutrients in the body. Digestive enzymes such as pancrelipase aid in the breakdown and digestion of lipids, carbohydrates, and proteins in food. Pancrelipase is used to treat to digestive problems variety of diseases such as pancreatitis, chronic pancreatitis, pancreatic cancer, cystic fibrosis, pancreatectomy, and post-gastrointestinal bypass surgery as in these conditions the production of digestive enzymes is hampered.
Surge in incidence of the pancreatitis and other pancreatic disorders is the major driver and upcoming pancrelipase market trends. Changing dietary habits of peoples due to adoption of modern lifestyle, surge in alcohol consumption causes various digestive health disorders, thus driving the pancrelipase market forecast. Pancrelipase helps in the digestion of patients suffering from these diseases due to a lack of digestive enzymes owing to their disease condition. Thus, increasing digestive problems boosts the demand for pancrelipase thereby drives the market growth.
In past decade there is significant rise in pancreatic cancer. For an instance according to the National Cancer Institute, in 2019, there were an estimated 89,248 people living with pancreatic cancer in the U.S. The rate of new cases of pancreatic cancer was 13.3 per 100,000 men and women per year. The death rate was 11.1 per 100,000 men and women per year. In addition, pancrelipase is primary treatment for exocrine pancreatic insufficiency which fuels the market growth.
However, high cost associated with drug development and strict regulatory standards expected to hinder market growth. Conversely, increasing purchasing power of developing nations is lucrative opportunity for the market growth.
The pancrelipase market analysis is segmented by application, age, distribution channel and region. By application, the pancrelipase market size is segmented into chronic pancreatitis, cystic fibrosis and others. The chronic pancreatitis segment generated maximum revenue in 2021, and also expected to witness highest CAGR during the forecast period, owing to high prevalence of the chronic pancreatitis and upsurge in the alcohol consumption.
By age, the pancrelipase market size is segmented into children and adult & geriatric. The adult & geriatric segment generated maximum revenue in 2021, and also expected to witness highest CAGR during the forecast period, owing to high incidence of the pancreatic cancer in adults and digestive disorders are more common in adult & geriatric population.
Depending on distribution channel, the pancrelipase industry is divided into hospital pharmacies, drug store & retail pharmacies and online pharmacies. The drug store & retail pharmacies segment dominated the pancrelipase market share in 2021, owing to increase in sell of prescription drugs and are also required in high quantities which increases dependence on drug stores. The online pharmacies segment is expected to witness highest CAGR during the forecast period owing to convenience and cheaper costs of purchasing prescription drugs electronically.
North America accounted for a majority of the global pancrelipase market share in 2021, and is anticipated to remain dominant during the forecast period. This is attribute surge in incidence of chronic pancreatitis, rise in awareness about usage of pancrelipase, presence of key players and robust hospital infrastructure in the region. However, Asia-Pacific is anticipated to witness notable growth, owing rise in incidence pancreatic cancer, development of healthcare infrastructure and increase in investments projects in the region.
Key findings of the study
- By application, the chronic pancreatitis segment was the highest contributor to the market in 2021.
- By age, the adult & geriatric segment was the highest contributor to the pancrelipase industry in 2021.
- Depending on distribution channel, the drug store & retail pharmacies segment was highest contributor in 2021, and is expected to continue this trend during the forecast period.
- Region wise, North America garnered the largest revenue share in 2021, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.
Companies Mentioned
- Abbvie Inc.
- Digestive Care, Inc.
- Nestlé S.A
- Organon Canada Inc.
- Viatris Inc.
- Vivus LLC
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 157 |
| Published | October 2022 |
| Forecast Period | 2021 - 2031 |
| Estimated Market Value ( USD | $ 1760.41 million |
| Forecasted Market Value ( USD | $ 2687.39 million |
| Compound Annual Growth Rate | 4.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 6 |
